Ramsay Generale dente (XPAR:GDS) ROCE % : 3.11% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Ramsay Generale dente ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ramsay Generale dente's annualized ROCE % for the quarter that ended in Dec. 2023 was 3.11%.

Ramsay Generale dente ROCE % Historical Data

The historical data trend for Ramsay Generale dente's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ramsay Generale dente ROCE % Chart

Ramsay Generale dente Annual Data

Trend

Dec13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

4.20

4.02

4.39

5.75

4.50

Ramsay Generale dente Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															5.95	5.54	5.08	3.83	3.11

Ramsay Generale dente ROCE % Calculation

Ramsay Generale dente's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	242.3	/	( ( (6787.9 - 1485.4)	+	(6957.8 - 1492.6) )	/ 2 )
	=	242.3	/	( (5302.5	+	5465.2)	/ 2 )
	=	242.3	/	5383.85
	=	4.50 %

Ramsay Generale dente's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	169.2	/	( ( (6957.8 - 1492.6)	+	(6861.1 - 1454.5) )	/ 2 )
	=	169.2	/	( ( 5465.2	+	5406.6 )	/ 2 )
	=	169.2	/	5435.9
	=	3.11 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Ramsay Generale dente (XPAR:GDS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ramsay Generale dente ROCE % Related Terms

Thank you for viewing the detailed overview of Ramsay Generale dente's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ramsay Generale dente (XPAR:GDS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ramsay Generale de Sante SA (XPAR:GDS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017

Website

https://www.ramsaygds.fr

Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.